From the Desk of Steve Strazza and Alfonso Depablos
Today’s largest insider transaction is another Form 4 filing by the president and CEO and a director of Sarepta Therapeutics $SRPT.
Together, the two executives bought SRPT shares for a total of $5,9 million.